UroGen Pharma Ltd. (URGN) Operating cash flow 2016–2025
UroGen Pharma Ltd. (URGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$162.4MFY2025 · since FY2016: $4.2M → -$162.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$162.4M | -67.9% |
| FY2024 | -$96.8M | -26.7% |
| FY2023 | -$76.4M | +12.8% |
| FY2022 | -$87.6M | -3.1% |
| FY2021 | -$84.9M | +19.8% |
| FY2020 | -$105.9M | -49.1% |
| FY2019 | -$71.0M | -90.2% |
| FY2018 | -$37.3M | -290.2% |
| FY2017 | -$9.6M | -328.4% |
| FY2016 | $4.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice